Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control
BLINK2
1 other identifier
observational
248
1 country
2
Brief Summary
This project intends to provide important, previously unmet answers regarding biological associations with myopia (nearsightedness) progression in order to improve the ability to predict patients who are most likely to benefit from myopia control, as well as questions frequently posed by patients and practitioners about the side effects, mechanism, and discontinuation of soft bifocal contact lens myopia control. The first three aims examine the association between biological variables that can be measured non-invasively and myopia progression, and they will be conducted regardless of the outcome of the currently in progress BLINK Study. The last three specific aims will be conducted if soft bifocal contact lenses slowed myopia progression by 30% or more in the BLINK Study, and they can be investigated with very few additional measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2019
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2019
CompletedFirst Posted
Study publicly available on registry
September 6, 2019
CompletedStudy Start
First participant enrolled
September 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 4, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 4, 2024
CompletedResults Posted
Study results publicly available
May 6, 2026
CompletedMay 6, 2026
March 1, 2026
4.3 years
August 27, 2019
May 20, 2025
April 15, 2026
Conditions
Outcome Measures
Primary Outcomes (6)
The Statistical Correlation Between Three-year Change in Choroidal Thickness and Three-year Change in Axial Length
test the hypothesis that thinner subfoveal choroidal thickness (a layer of blood vessels) is associated with the outcome of greater axial elongation (eye growth) The hypothesis relates to the two years of multifocal contact lens wear and one year of single vision contact lens wear. As such, it uses the entire sample which experiences the same contact lens wear in the BLINK2 Study.
Three years
The Statistical Correlation Between iPRGC Activity at BLINK2 Baseline and Three-year Change in Axial Length
test the hypothesis that less ipRGC activity (cells in the back of the eye as measured by blue light-driven inputs to the pupil response - measured by the blue decay coefficient) as measured at the Baseline BLINK 2 is associated with greater axial elongation (eye growth) over three years The hypothesis relates to the two years of multifocal contact lens wear and one year of single vision contact lens wear. As such, it uses the entire sample which experiences the same contact lens wear in the BLINK2 Study.
Three years
The Statistical Correlation Between Light Levels Measured at Baseline and Three-year Change in Axial Length
test the hypothesis that exposure to light levels over 1000 lux as measured at the Baseline BLINK2 visit is associated with less axial elongation (eye growth) over three years The hypothesis relates to the two years of multifocal contact lens wear and one year of single vision contact lens wear. As such, it uses the entire sample which experiences the same contact lens wear in the BLINK2 Study.
Three years
Three-year Choroidal Thickness Change
The three-year change from baseline to three years for choroidal thickness.
3 years
Duration of Exposure to Light Levels Exceeding 1000 Lux at Baseline
Baseline light exposure as measured by minutes at light levels over 1000 lux. Light exposure was monitored using the Actiwatch2 (Phillips Respironics), a light-sensing and logging watch worn on the wrist. Participants wore the device for a 1 week period to monitor environmental light exposure. The illuminance was measured in lux every minute. Data were scrubbed of periods where the watch was not worn or other artifacts. Light levels over 1000 lux were added to determine time outdoors in minutes.
Baseline
Baseline iPRGC Activity
Baseline iPRGC activity (cells in the back of the eye as measured by blue light-driven inputs to the pupil response - measured by the blue decay coefficient). The Blue Decay Coefficient represents the rate at which the pupil redilates in the dark after exposure to multiple 5-second pulses of red and blue light. The redilation data are fit by an exponential decay function eβt where t is time in seconds and the coefficient β is the natural log of the percent change in pupil diameter per second. Values range from -0.30 to -0.01. More positive values represent slower pupil redilation and are associated with greater, potentially beneficial ipRGC activity.
Baseline
Secondary Outcomes (7)
Accommodative Amplitude
Baseline
Lag of Accommodation
Baseline
Accommodative Facility
Baseline
Slowing of Myopia Progression - Axial Length
Two year change (Baseline to 2-Year visit)
Rebound of Progression - Axial Length
One year change (2-year visit to 3-year visit)
- +2 more secondary outcomes
Study Arms (1)
Contact lens
The first two years of the study all participants will wear +2.50 D multifocal contact lenses. The last year of the study, all subjects will be wearing single vision contact lenses.
Interventions
2.50 D multifocal contact lens years 1 and 2. Year 3 all wear a single vision contact lens.
Eligibility Criteria
Only those participants in the original BLINK Study who have consented to continue will be enrolled in BLINK2.
You may qualify if:
- Participants in the BLINK Study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ohio State Universitylead
- University of Houstoncollaborator
Study Sites (2)
Ohio State University
Columbus, Ohio, 43210, United States
University of Houston
Houston, Texas, 77204, United States
Related Publications (1)
Chandler MA, Robich ML, Jordan LA, Mutti DO, Berntsen DA, Fenton R, Day E, Walline JJ; BLINK2 Study Group. Accommodation in Children after 4.7 Years of Multifocal Contact Lens Wear in the BLINK Study Randomized Clinical Trial. Optom Vis Sci. 2023 Jul 1;100(7):425-431. doi: 10.1097/OPX.0000000000002040. Epub 2023 Jun 24.
PMID: 37369096DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Jeffrey Walline
- Organization
- The Ohio State University
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey J Walline, OD PhD
The Ohio State University College of Optometry
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 27, 2019
First Posted
September 6, 2019
Study Start
September 9, 2019
Primary Completion
January 4, 2024
Study Completion
January 4, 2024
Last Updated
May 6, 2026
Results First Posted
May 6, 2026
Record last verified: 2026-03